GJB6 Gene Deafness autosomal dominant type 3B Genetic Test
At DNA Labs UAE, we offer the GJB6 Gene Deafness autosomal dominant type 3B Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Before undergoing the GJB6 Gene Deafness autosomal dominant type 3B Genetic Test, it is important to provide the clinical history of the patient. This includes any symptoms or conditions related to IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the gene IARS5.
Test Details
The GJB6 gene is associated with a type of deafness known as autosomal dominant type 3B (DFNA3B). This genetic condition causes progressive hearing loss that usually begins in childhood or adolescence. The NGS (Next-Generation Sequencing) technology allows for the simultaneous analysis of multiple genes or even the entire exome in a person’s DNA. In the case of GJB6 gene deafness, the NGS genetic test involves sequencing the GJB6 gene to identify any mutations or variations that may be responsible for the individual’s hearing loss.
By identifying specific mutations in the GJB6 gene, the NGS testing can provide a definitive diagnosis for individuals with autosomal dominant type 3B deafness. This information is valuable for understanding the underlying cause of the hearing loss, predicting disease progression, and potentially guiding treatment options or interventions.
Test Name | GJB6 Gene Deafness autosomal dominant type 3B Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS5 |
Test Details |
The GJB6 gene is associated with a type of deafness known as autosomal dominant type 3B (DFNA3B). This genetic condition causes progressive hearing loss that typically starts in childhood or adolescence. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes or even the entire exome (all protein-coding genes) in a person’s DNA. In the context of GJB6 gene deafness, an NGS genetic test would involve sequencing the GJB6 gene to identify any mutations or variations that may be responsible for the individual’s hearing loss. By identifying specific mutations in the GJB6 gene, NGS testing can provide a definitive diagnosis for individuals with autosomal dominant type 3B deafness. This information can be valuable for understanding the underlying cause of the hearing loss, predicting disease progression, and potentially guiding treatment options or interventions. |